Chronic Myeloid Leukemia Clinical Trials in Nantes
3 recruitingNantes, France
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase
Terns, Inc.180 enrolled54 locationsNCT06163430
Recruiting
Phase 2
Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
Chronic Myeloid Leukemia (CML)
Novartis Pharmaceuticals20 enrolled2 locationsNCT06514534
Recruiting
Phase 3
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Chronic Myeloid LeukemiaTyrosine Kinase Inhibitors
Poitiers University Hospital140 enrolled20 locationsNCT05753384